Gullberg U, Lindmark A, Lindgren G, Persson A M, Nilsson E, Olsson I
Department of Medicine, University of Lund, Sweden.
J Biol Chem. 1995 May 26;270(21):12912-8. doi: 10.1074/jbc.270.21.12912.
The hematopoietic neutral serine proteases leukocyte elastase and cathepsin G are synthesized as inactive precursors, but become activated by removal of an amino-terminal dipeptide and are stored in granules. Moreover, the pro forms of elastase and cathepsin G show carboxyl-terminal prodomains of 20 and 11 amino acids, respectively, which are not present in the mature enzymes. To investigate mechanisms of processing, activation, and granular targeting, we have utilized transgenic expression of myeloid serine proteases in the rat basophilic/mast cell line RBL-1 (Gullberg, U., Lindmark, A., Nilsson, E., Persson, A.-M., and Olsson, I. (1994) J. Biol. Chem. 269, 25219-25225). Leukocyte elastase was stably expressed in RBL-1 cells, and the translation products were characterized by biosynthetic labeling followed by immunoprecipitation, SDS-polyacrylamide gel electrophoresis, and fluorography. Processing of a main pro form of 34 kDa into mature 31- and 29-kDa forms was demonstrated. Translocation of mature forms to granule-containing fractions was shown by subcellular fractionation experiments. The processed forms were enzymatically active, judging by the occurrence of amino-terminal processing demonstrated by radiosequence analysis, the acquisition of affinity for the protease inhibitor aprotinin, and the appearance of elastase activity in transfected RBL cells. To investigate the function of the carboxyl-terminal prodomains, deletion mutants of leukocyte elastase and cathepsin G lacking the carboxyl-terminal extension were constructed and transfected into RBL cells. Our results show that as full-length proteins, the deletion mutants were converted to active enzymes and transferred to granules with kinetics similar to that of wild-type enzymes. We conclude that human leukocyte elastase and cathepsin G are converted into enzymatically active forms when expressed in RBL cells and targeted for storage in granules; the carboxyl-terminal prodomains are necessary neither for enzymatic activation nor for targeting to granules in RBL cells.
造血中性丝氨酸蛋白酶白细胞弹性蛋白酶和组织蛋白酶G以无活性前体形式合成,但通过去除氨基末端二肽而被激活,并储存于颗粒中。此外,弹性蛋白酶和组织蛋白酶G的前体形式分别显示出20个和11个氨基酸的羧基末端前结构域,这些结构域在成熟酶中不存在。为了研究加工、激活和颗粒靶向的机制,我们利用了大鼠嗜碱性/肥大细胞系RBL-1中髓系丝氨酸蛋白酶的转基因表达(古尔伯格,U.,林德马克,A.,尼尔森,E.,佩尔松,A.-M.,和奥尔松,I.(1994年)《生物化学杂志》269,25219-25225)。白细胞弹性蛋白酶在RBL-1细胞中稳定表达,翻译产物通过生物合成标记、免疫沉淀、SDS-聚丙烯酰胺凝胶电泳和荧光自显影进行表征。证实了一种主要的34 kDa前体形式加工成成熟的31 kDa和29 kDa形式。通过亚细胞分级分离实验表明成熟形式易位至含颗粒级分。根据放射性序列分析显示的氨基末端加工、对蛋白酶抑制剂抑肽酶亲和力的获得以及转染的RBL细胞中弹性蛋白酶活性的出现判断,加工后的形式具有酶活性。为了研究羧基末端前结构域的功能,构建了缺失羧基末端延伸的白细胞弹性蛋白酶和组织蛋白酶G的缺失突变体,并将其转染到RBL细胞中。我们的结果表明,作为全长蛋白,缺失突变体被转化为活性酶,并以与野生型酶相似的动力学转移至颗粒中。我们得出结论,人白细胞弹性蛋白酶和组织蛋白酶G在RBL细胞中表达时被转化为酶活性形式,并靶向储存于颗粒中;羧基末端前结构域对于RBL细胞中的酶激活和颗粒靶向均非必需。